WaveSense, Inc. dba nRichDX

nRichDX is a biotechnology company specializing in advanced sample preparation systems for liquid biopsy and precision medicine diagnostics. The company's flagship Revolution Sample Prep Platform™ enables high-yield extraction of circulating tumor DNA (ctDNA), circulating tumor RNA (ctRNA), and circulating tumor cells (CTCs) from multiple biofluids including plasma, whole blood, urine, cerebrospinal fluid, and peritoneal fluid. The Revolution Plus semi-automated instrument processes sample volumes from 1 mL to 100 mL in a single extraction, significantly improving analyte yield compared to traditional spin-column and vacuum-based methods. nRichDX addresses a critical limitation in liquid biopsy workflows—sample preparation sensitivity—through its proprietary nRicher Cartridge technology that eliminates multiple sample transfers and yield-lowering procedures. The company offers a comprehensive portfolio of Revolution Kits optimized for different analytes (cfDNA, cfRNA, cfTNA, CTCs) and sample types, supporting early cancer detection, infectious disease testing, and neurological disease research. nRichDX serves clinical laboratories, academic medical centers, and molecular diagnostics companies requiring sensitive detection of rare circulating biomarkers. The platform integrates with automation partners including Hamilton liquid handlers for fully scalable workflows.